EYE » Topics » Laser Vision Correction (LVC) sales rose 91.2 percent to $102.1 million.
This excerpt taken from the EYE 8-K filed Aug 2, 2007.
Laser Vision Correction (LVC) sales rose 91.2 percent to $102.1 million.
Pro forma LVC sales increased 17.0 percent.
Procedures and related sales of $63.6 million represented a 74.9 percent increase, or 25.6 percent on a pro forma basis.
AMOs U.S. LASIK procedure volumes grew 13.2 percent and its U.S. custom procedure mix reached 62.4 percent for the trailing 12 months ended June 29.
AMOs U.S. femtosecond procedure volumes grew 36.6 percent for the trailing 12 months ended June 29 on a pro forma basis.
International procedure sales were $16.1 million, which included excimer procedure sales of $5.2 million, up 61.4 percent, and femtosecond procedure sales of $10.9
million, up 98.1 percent on a pro forma basis.
2
System sales increased 190.5 percent to $28.5 million, or an increase of 6.4 percent on a pro forma basis. On a unit
basis, placements of the VISX Star S4 IR® excimer laser rose 47 percent; IntraLase® FS laser placements rose 23 percent on a pro
forma basis.
Bet you've never seen portfolio analytics like these.